Zobrazeno 1 - 10
of 124
pro vyhledávání: '"ctDNA, circulating tumor DNA"'
Autor:
Thien-Phuc Nguyen Hoang, Tien Anh Nguyen, Nam H. B. Tran, Van-Anh Nguyen Hoang, Hong Thuy Thi Dao, Vu-Uyen Tran, Yen Nhi Nguyen, Anh Tuan Nguyen, Cam Tu Nguyen Thi, Thanh Thuy Do Thi, Duy Sinh Nguyen, Hoai-Nghia Nguyen, Hoa Giang, Lan N. Tu
Publikováno v:
Frontiers in Molecular Biosciences, Vol 11 (2024)
Background: Biomarker testing has gradually become standard of care in precision oncology to help physicians select optimal treatment for patients. Compared to single-gene or small gene panel testing, comprehensive genomic profiling (CGP) has emerged
Externí odkaz:
https://doaj.org/article/ae651664723c4299904e6fc53538c2fe
Autor:
Ana Jiménez-Ubieto, Alejandro Martín-Muñoz, María Poza, Sara Dorado, Almudena García-Ortiz, Enrique Revilla, Pilar Sarandeses, Yanira Ruiz-Heredia, Tycho Baumann, Antonia Rodríguez, María Calbacho, Pilar Martínez Sánchez, José María Sánchez Pina, Alejandro Martín García-Sancho, Gloria Figaredo, Daniel Gil-Alós, Laura Rufián, Margarita Rodríguez, Laura Carneros, Carolina Martínez-Laperche, Mariana Bastos-Oreiro, Chongwu Wang, María-Teresa Cedena, Inmaculada Rapado, Paula de Toledo, Miguel Gallardo, Antonio Valeri, Rosa Ayala, Joaquín Martínez-López, Santiago Barrio
Publikováno v:
Frontiers in Immunology, Vol 14 (2024)
Externí odkaz:
https://doaj.org/article/6180b4e41d7e48c3aa85430dc0d50bae
Autor:
Ana Jiménez-Ubieto, Alejandro Martín-Muñoz, María Poza, Sara Dorado, Almudena García-Ortiz, Enrique Revilla, Pilar Sarandeses, Yanira Ruiz-Heredia, Tycho Baumann, Antonia Rodríguez, María Calbacho, Pilar Martínez Sánchez, José María Sánchez Pina, Alejandro Martín García-Sancho, Gloria Figaredo, Laura Rufián, Margarita Rodríguez, Laura Carneros, Carolina Martínez-Laperche, Mariana Bastos-Oreiro, Chongwu Wang, María-Teresa Cedena, Inmaculada Rapado, Paula de Toledo, Miguel Gallardo, Antonio Valeri, Rosa Ayala, Joaquín Martínez-López, Santiago Barrio
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Externí odkaz:
https://doaj.org/article/85d6ea9ac18848589608d5c77dbb5343
Autor:
Ana Jiménez-Ubieto, Alejandro Martín-Muñoz, María Poza, Sara Dorado, Almudena García-Ortiz, Enrique Revilla, Pilar Sarandeses, Yanira Ruiz-Heredia, Tycho Baumann, Antonia Rodríguez, María Calbacho, Pilar Martínez Sánchez, José María Sánchez Pina, Alejandro Martín García-Sancho, Gloria Figaredo, Daniel Gil-Alós, Laura Rufián, Margarita Rodríguez, Laura Carneros, Carolina Martínez-Laperche, Mariana Bastos-Oreiro, Chongwu Wang, María-Teresa Cedena, Inmaculada Rapado, Paula de Toledo, Miguel Gallardo, Antonio Valeri, Rosa Ayala, Joaquín Martínez-López, Santiago Barrio
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
BackgroundCART therapy has produced a paradigm shift in the treatment of relapsing FL patients. Strategies to optimize disease surveillance after these therapies are increasingly necessary. This study explores the potential value of ctDNA monitoring
Externí odkaz:
https://doaj.org/article/1d554d9f1fd5420eabc9eb1cd0499e0c
Autor:
Thi Mong Quynh Pham, Thanh Hai Phan, Thanh Xuan Jasmine, Thuy Thi Thu Tran, Le Anh Khoa Huynh, Thi Loan Vo, Thi Huong Thoang Nai, Thuy Trang Tran, My Hoang Truong, Ngan Chau Tran, Van Thien Chi Nguyen, Trong Hieu Nguyen, Thi Hue Hanh Nguyen, Nguyen Duy Khang Le, Thanh Dat Nguyen, Duy Sinh Nguyen, Dinh Kiet Truong, Thi Thanh Thuy Do, Minh-Duy Phan, Hoa Giang, Hoai-Nghia Nguyen, Le Son Tran
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
IntroductionBreast cancer causes the most cancer-related death in women and is the costliest cancer in the US regarding medical service and prescription drug expenses. Breast cancer screening is recommended by health authorities in the US, but curren
Externí odkaz:
https://doaj.org/article/fd3dc91b55a34d71b55f7627f7b547b1
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Liquid biopsy assays for minimal residual disease (MRD) are used to monitor and inform oncological treatment and predict the risk of relapse in cancer patients. To-date, most MRD assay development has focused on targeting somatic mutations. However,
Externí odkaz:
https://doaj.org/article/19956497539d450ebf6d0e1d9f6c3cab
Autor:
Frontiers Production Office
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Externí odkaz:
https://doaj.org/article/c6004706918d4b2283d2cb7cdd4212fc
Autor:
Quentin Dominique Thomas, Julien Colard-Thomas, Delphine Delansay, Fanny Leenhardt, Jerome Solassol, Julie A. Vendrell, Xavier Quantin
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
The detection of circulating tumor DNA (ctDNA) by liquid biopsy is taking an increasing role in thoracic oncology management due to its predictive and prognostic value. For non-small cell lung cancer, it allows the detection of molecular mutations th
Externí odkaz:
https://doaj.org/article/c4256822ac1d4b32936effa6be87ef77
Publikováno v:
Frontiers in Endocrinology, Vol 13 (2022)
BackgroundAfter early-line (first- and second-line) endocrine therapy, hormone-receptor (HR)-positive and human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancers (mBCs) become resistant to endocrine therapy. Genetic alterat
Externí odkaz:
https://doaj.org/article/46f06651406649088fe5451e53e68c93
Autor:
Stéphanie Gonvers, Parissa Tabrizian, Emmanuel Melloul, Olivier Dormond, Myron Schwartz, Nicolas Demartines, Ismail Labgaa
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Liver transplant (LT) is the most favorable treatment option for patients with early stage hepatocellular carcinoma (HCC). Numerous attempts have been pursued to establish eligibility criteria and select HCC patients for LT, leading to various system
Externí odkaz:
https://doaj.org/article/8b354bd8b57349439303172546868422